Associated Papers
Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.
Passet M et al.
Blood, 2022
35316324 (PubMed )
Supplement: 10.1182-2021014723_bloodbld2021014723-suppl1.pdf
Select a paper to view details